Objectives-Our aims in this study were as follows: (1) to determine the cutoff value that can distinguish between advanced liver fibrosis and normal liver tissue for two different elastographic techniques; (2) to determine the cutoff value that can distinguish mild liver fibrosis from normal liver tissue for the techniques; and (3) to assess tissue stiffness in nonalcoholic fatty liver disease (NAFLD).
N
oninvasive quantitative methods such as point shear wave elastography are used to measure tissue stiffness. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] An alternative method of biopsy in children is becoming increasingly necessary. This technique sends ultrasonic pulses focused on the tissues and is based on the measurement of shear waves moving away from the focal zone. The shear wave speed (SWS) is measured in meters per second. When the hardness of the tissue increases, the speed of the shear waves also increases (although the rate of this increase is not directly proportional). Therefore, an increase in SWS means an increase in tissue stiffness. 7, 9, [12] [13] [14] [15] [16] [17] [18] In several studies on the use of point shear wave elastography in liver fibrosis in childhood, SWS values increased positively with the degree of histologic fibrosis. 7, 13, 14 The correlation coefficient between increased SWS values and the histologic fibrosis stage increased in comparison with SWS values for advanced fibrosis and normal liver tissue. There is limited information on the role of point shear wave elastography in differentiating liver fibrosis from low-grade histologic scores, and the previously published studies were performed with small patient groups. 4, 7 Our aims in this study were as follows: (1) to determine the cutoff value that can distinguish between advanced fibrosis and normal liver tissue for two different elastographic techniques; (2) to determine the cutoff value that can distinguish mild liver fibrosis from normal liver tissue for the techniques; and (3) to assess tissue stiffness in nonalcoholic fatty liver disease (NAFLD).
Materials and Methods

Study Design
This work was a prospective study. Patients were enrolled in the study between April 2015 and March 2016. Approval was obtained from the Ethical Committee of the hospital, and informed consent was obtained from the parents or guardians of all participants.
Patients
The time frame of this study was April 2015 to March 2016. In the study, the cohort was divided into 3 groups. Group 1 consisted of the healthy volunteers; group 2 consisted of patients with chronic liver disease who underwent liver biopsy; and group 3 consisted of overweight or obese children with disorders such as NAFLD.
The healthy volunteer group was examined by abdominal sonography to rule out any preexisting liver diseases. The children were not taking any medications. Their body mass index (BMI) was calculated from their height and weight according to the World Health Organization anthropometric program (WHO Anthro, version 3.2.2; World Health Organization, Geneva, Switzerland) for children younger than 5 years or according to the World Health Organization BMI-forage percentile reference tables for children older than 5 years.
Children with a BMI for age above the 95th percentile and hepatic enzyme abnormalities but a conventional sonographic appearance consistent with the parenchymal findings of fatty liver disease were included in the NAFLD group. The inclusion criteria involved any child undergoing a clinically indicated percutaneous liver biopsy at our institution. Liver biopsies were performed by interventional radiology physicians. Exclusion criteria included patients whose pathologic specimens were deemed inadequate for assessment or were physically unavailable for review.
The chronic liver disease group had several etiologic factors varying from chronic viral hepatitis, autoimmune hepatitis, a 1 -antitrypsin deficiency, and Wilson disease to biliary atresia. Those with chronic liver diseases were referred for liver biopsy from pediatric gastroenterology physicians.
Elastographic Measurements
In this study, the point shear wave elastographic measurements were obtained with an Acuson S2000 ultrasound system equipped with a 9L4 transducer (Siemens Medical Solutions, Mount View, CA). Shear wave elastography was conducted with the child supine and free breathing unless the child was older and was able to hold his or her breath. The measurements were performed by a senior radiologist who was blinded to the pathologic results. The point shear wave elastographic measurements were taken on the same day as or 1 day before the biopsy procedure. Also, none of the biopsy procedures were conducted by the radiologist, and none of the patients with NAFLD underwent biopsy procedures. The patients were referred by pediatric gastroenterologists, and the patients with NAFLD were referred by pediatric endocrinologists.
In our study, Virtual Touch quantification (VTQ) and Virtual Touch imaging and quantification (VTIQ) techniques were used. The VTQ technique can be done with either a 9L4 or a 4C1 transducer, but the VTIQ technique can only be done with the 9L4 transducer. In our study, all of the patients were examined with the 9L4 transducer. During the examination, the region of interest was placed at least 10 mm below the liver capsule. The main aim was to avoid biliary and vascular structures in the defined regions of interest. At least 6 valid measurements were made for each patient. The minimum pressure required for the transducer was applied during the measurement (Figures 1-3 ).
Histopathologic Assessment
The pathologist was blinded to the SWS measurements. Specimens with 3 or fewer portal tracts were excluded for the analysis. Knodell histopathologic scoring systems
F1-F3
were used. The Knodell histologic evaluation grades 6 stages of fibrosis; F1 displays no portal fibrosis; F2 shows portal fibrosis without septa; F4 shows portal fibrosis with few septa; F5 displays portal fibrosis with numerous septa; and F6 indicates end-stage cirrhosis. The F3 level corresponds to the pathologic correlation of fibrosis with the initial stage of bridging necrosis, which is accepted as the irreversible stage. The presence or absence of steatosis and rejection was noted, but a steatosis grading scale was not used. The liver slides were directly reviewed by light microscopy. None of the slides were sent out of the institute or were used in any other multicenter study.
Statistical Analysis
To determine the diagnostic accuracy of the point shear wave elastographic measurements compared with the pathologic correlation of liver staging, receiver operator curves were used. For each stage, the areas under the curves (AUROCs) were also calculated. Comparisons among groups used parametric and nonparametric tests. The Student t test and the nonparametric MannWhitney U test were used as appropriate. For more than 2 group comparisons, analysis of variance was used. Analysis of variance with post hoc tests was used to compare the VTQ and VTIQ mean SWS measurements in children with different histologic fibrosis scores. Multiple linear regression analysis was used to determine the relationship between the SWS and the covariant variables, including histologic fibrosis, age, and sex for both VTQ and VTIQ. For the descriptive data, parametric tests, and nonparametric tests, SPSS version 21.0 software (IBM Corporation, Armonk, NY) was used. For the receiver operating characteristic curves, AUROC assessments and index calculations in MedCalc statistical software (MedCalc Software, Ostend, Belgium) were used. The graphics were drawn with the MedCalc program.
Results
Study Population: Patients Who Underwent a Biopsy Procedure Seventy-five patients met the initial inclusion criteria, and 7 patients were excluded for inadequate or unavailable histologic specimens. The VTQ measurements were successful in 68 patients. The median age of the group was 5.7 years (range, 2-12 years). There was a . Most patients (60 of 68) had serum studies on the same day as the biopsy, with a minority of patients who had serum studies within the previous week (5 of 68) and 3 patients within the previous month.
The VTIQ measurements were successful in 61 children, including 39 girls and 22 boys. The median patient age was 4.6 years (range, 2.6-12 years Figure 4B ). The SWS was significantly higher in patients with moderate fibrosis (F4-F6) compared with patients with mild to no fibrosis (F1-F3; P 5 .02). The median SWS was calculated as 2.09 m/s (IQR, 0.33 m/s) for the patients with moderate fibrosis. The median SWS for moderate fibrosis was statistically significantly higher than that for slight fibrosis (P 5 .014; Figure 5 ).
For the control group, the median SWS was 1.24 m/s (IQR, 0.32 m/s). For the patients with NAFLD, the median SWS was 1.56 m/s (range, 1.32-2.03 m/s). For the elastographic correlation with steatosis and BMI, the SWS was significantly different between the 11 patients with steatosis and the 31 patients in the control group (P 5 .01). There was no correlation between BMI and SWS (Spearman q 5 0.065; P 5 .849).
Multiple Regression Analysis for VTQ and VTIQ
For VTQ with respect to the multiple regression analysis, histologic fibrosis was found to be the only significant predictor of SWS (P < .001). Age and sex were not significant predictors (P 5 .12 and .41, respectively). According to the multiple regression analysis, the adjusted R 2 value was calculated as 0.5852. For VTIQ with respect to the multiple regression analysis, histologic fibrosis was found to be the only significant predictor of SWS (P < .001). Sex and age were not significant predictors (P 5 .82 and .57). According to the multiple regression analysis, the adjusted R 2 value was calculated as 0.7564.
Receiver Operating Characteristic Curve Analysis and Selection of the SWS Cutoff Value
Receiver operating characteristic curves for discriminating low histologic fibrosis scores (F0-F2) versus high histologic scores (F3-F6) using median SWS measurements were calculated. The AUROC for VTQ was 0.83 (95% confidence interval [CI], 0.731-0.918), and the AUROC for VTIQ was 0.851 (95% CI, 0.737-0.929). Shear wave speed cutoff values of 2.09 m/s for VTQ (sensitivity, 63%; specificity, 97%) and 2.17 m/s for VTIQ (sensitivity, 65%; specificity, 95%) were calculated ( Figure 6 ).
For substantial fibrosis, the AUROCs were calculated as 0.985 for VTQ and 0.992 for VTIQ. Shear wave speed cutoff values of 2.17 m/s for VTQ (sensitivity, 76%; specificity, 100%) and 2.24 m/s for VTIQ (sensitivity, 77%; specificity, 100%) were calculated for a high histologic fibrosis score. For discriminating low-grade histologic scores from normal liver tissue, the AUROCs were calculated as 0.865 for VTQ and 0.769 for VTIQ, with SWS cutoff values of 1.67 m/s (sensitivity, 53%; specificity, 100%) for VTQ and 1.56 m/s (sensitivity, 55%; specificity, 100%) for VTIQ.
Discussion
In the literature, a positive correlation between shear wave elastographic values and liver fibrosis has been reported. 4, 7, 13, 14 This correlation coefficient was higher in cases in which cirrhotic liver tissue was compared with normal tissue. 4, 7 In everyday clinical practice, it will be useful to determine the SWS values necessary to effectively detect histologic tissue and avoid unnecessary biopsies. In our study, AUROC values were highest for marked fibrosis and cirrhosis, whereas they were lower in distinguishing substantial fibrosis from mild cirrhosis. The lowest values were obtained when comparing normal liver tissue and low histologic fibrotic scores.
However, all of these values were above the acceptable value of 0.5 for the receiver operating characteristic curves. In this case, we can say that point shear wave elastography can be used to evaluate childhood liver fibrosis. However, the low AUROC values obtained from elastography should be questioned in terms of its use in distinguishing early-stage fibrosis in a healthy group. The low success rate of liver histologic scores may be due to the absence of substantial structural distortion in the liver tissue at this stage. 4, 7 In our study, the cutoff values for normal liver tissue and a low histopathologic fibrosis score were 1.67 m/s for VTQ and 1.56 m/s for VTIQ. These results were similar to those found by Phelps et al 7 and Dillman et al. 4 For VTQ, using a similar method, an SWS value of 1.56 m/s was determined by Tutar et al. 13 For VTIQ, our value was lower than that of Dillman et al. 4 The cutoff values for high-and low-grade histologic fibrosis A multivariate regression analysis was performed to determine the relationship between the liver SWS values and the predictive factors that affect them. The histologic fibrosis score was determined to be a predictive value for VTQ and VTIQ. This finding was also evidenced by Dillman et al 4 in their analysis. This information suggests that point shear wave elastography is an effective method for determining histologic fibrosis. Sex and age were not predictive determinants for either VTQ or VTIQ. Unlike other studies, the presence of the control group in our study supported more precise statistical results.
The result of the multivariate analysis was that the adjusted R 2 values were calculated as 0.75 for VTIQ and 0.58 for VTQ. In this case, approximately 75% of the patients who participated in the study and were analyzed for histologic fibrosis scores with VTIQ could be explained by this result. The percentage for VTQ was 58%. For VTIQ, Dillman et al 4 found a rate of 56%. Also, because the adjusted R 2 value obtained for VTIQ was greater than that for VTQ, VTIQ could be a more appropriate screening tool for liver fibrosis in pediatric patients. However, in both cases, there were unexplained variations of 25% for VTIQ and 42% for VTQ. This finding suggests that the relationship between SWS and the histopathologic fibrosis grade is not linearly dependent and may be a nonlinear correlation.
In our study, unlike in other studies, patients with NAFLD were evaluated with the point shear wave elastography, and the median SWS value was estimated to be approximately 1.56 m/s for these patients. This SWS value was close to the low-grade histopathologic value. In this case, patients with early-stage NAFLD are likely to have histopathologic changes that do not cause substantial tissue distortion. However, this information needs to be evaluated by biopsy.
There were some limitations in our work. First, approximately half of the patients in our study who underwent biopsies had a low-grade histopathologic score. A total of 8 patients with late-stage cirrhosis (F5 and F6 stages) constituted approximately 10% to 13% of the total number of biopsies. Evaluation of these advanced cirrhotic cases will provide a better understanding of the histopathologic correlation with point shear wave elastography. Additional studies with larger cohort groups would be better for evaluating cutoff values with higher, more trustworthy, rates. Second, measurements from different depths are obtained within the region of interest by the VTIQ technique, although the effects of depth on point shear wave elastography were not evaluated in our study.
In conclusion, as the level of histopathologic liver fibrosis increases, the SWS values on point shear wave elastography are also increased. The VTQ and VTIQ values reveal high-grade histopathologic fibrosis and have high success rates when distinguishing it from lowgrade fibrosis. However, low-grade fibrosis has limited success rates in differentiating it from normal liver tissue. As a result of the multiple linear regression analysis, the histologic fibrosis score was determined to be the only significant predictive value for the SWS values on point shear wave elastography. In patients with NAFLD, point shear wave elastography yields SWS values that are near those for low-grade fibrosis. 
